Pharmacoeconomic Review
Authors
- Pages
- 170
- Published in
- Canada
CADTH Reimbursement Review Optimal Pharmacotherapy for Transplant-Ineligible Multiple Myeloma - PROSPERO Registration Number: CRD42021255578
15 Apr 2024
Accessing this content requires a membership
If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.
Add to list
Citation
Health, C., 2024. CADTH Reimbursement Review Optimal Pharmacotherapy for Transplant-Ineligible Multiple Myeloma - PROSPERO Registration Number: CRD42021255578, Canadian Agency for Drugs and Technologies in Health.
Canada.
Retrieved from https://coilink.org/20.500.12592/8gtj0xm on 23 Oct 2024. COI: 20.500.12592/8gtj0xm.
Full-page Screenshot
